AstraZeneca To Add Defendant In Nexium Patent Suit
AstraZeneca Corp. has won a bid to add a defendant, Cipla Ltd., and a patent to its infringement suit against Teva Pharmaceutical Industries Inc. and its Ivax Corp. subsidiary over patents...To view the full article, register now.
Already a subscriber? Click here to view full article